Medical news
Each update carries a summary written by WellCareChina with AI assistance, the source name, the date, and a link to the original.
-
AI-assisted summary
Phase 1 trial of in vivo CAR-T therapy for relapsed AML registered in Beijing
A study registered on ClinicalTrials.gov on 25 September 2026 plans to test an in vivo CAR-T therapy targeting CLL-1 in up to 12 adults with relapsed or refractory acute myeloid leukaemia at the Chinese PLA General Hospital in Beijing. The record describes a single-arm phase 1 dose-escalation design, lists an estimated start date of 30 […]
-
AI-assisted summary
Phase 2 lung cancer trial with Chinese sites is recruiting
A phase 2 study registered on ClinicalTrials.gov and updated on 25 September 2026 is recruiting about 130 patients with non-small cell lung cancer to test an investigational drug given with chemoradiation followed by consolidation immunotherapy. The listed sites include hospitals in Dongguan, Guangzhou and Jinan. The sponsor is Johnson & Johnson Enterprise Innovation Inc. Registry […]
-
AI-assisted summary
Chinese teams publish phase 1 gene therapy results in adolescents with haemophilia B
The Chinese Academy of Medical Sciences said on 24 September 2026 that teams from its Institute of Hematology, Tongji Hospital and a biotechnology company published a phase 1 trial of an AAV gene therapy in adolescents with haemophilia B in Nature Medicine. The academy’s account describes the results as preliminary evidence for this age group. […]
-
AI-assisted summary
Guangdong runs a cross-border exercise for its Hong Kong-Macao drug and device scheme
The Guangdong Medical Products Administration said it held an exercise in Nansha on 23 September 2026 testing emergency response for the scheme that lets designated mainland hospitals in the Greater Bay Area use drugs and medical devices approved in Hong Kong or Macao. The administration said the scheme has covered 71 designated institutions, 178 products […]
-
AI-assisted summary
Phase 2 colorectal cancer trial opens at Guangdong Provincial People’s Hospital
A phase 2 study registered on ClinicalTrials.gov and last updated on 24 September 2026 is recruiting about 160 patients with refractory RAS wild-type metastatic colorectal cancer. The record names Guangdong Provincial People’s Hospital in Guangzhou as the sponsor and site and lists bevacizumab, sintilimab, cetuximab and irinotecan; the stated primary endpoint is objective response rate. […]
-
AI-assisted summary
Phase 3 trial of an autologous cell therapy for COPD registered at a Guangzhou hospital
A study registered on ClinicalTrials.gov and last updated on 24 September 2026 plans to test an autologous cell therapy, REGEND001, made from airway basal stem cells, in about 102 adults with chronic obstructive pulmonary disease and emphysema. The record describes a multicentre, randomised, blinded, placebo-controlled phase 3 trial at The First Affiliated Hospital of Guangzhou […]
-
AI-assisted summary
China’s traditional medicine regulator reviews digital projects
The National Administration of Traditional Chinese Medicine said it held a meeting in Chongqing on 20-21 September 2026 with the National Data Administration and other organisations on digital projects in traditional Chinese medicine, including data pilot zones. The administration said it would set out a digital roadmap intended to improve access to traditional medicine services. […]
-
AI-assisted summary
China issues a standard for AI-powered brain-computer interface devices
CGTN reported on 14 September 2026 that China’s National Medical Products Administration issued what the regulator describes as the world’s first product standard for brain-computer interface medical devices that use artificial intelligence to process EEG data. The standard sets requirements for data collection, processing, annotation, storage and access, and takes effect on 1 September 2027.
-
AI-assisted summary
Chinese eye team performs cataract surgery in Uzbekistan, Xinhua reports
Xinhua reported on 12 September 2026 that a team from Peking University People’s Hospital sent to Samarkand under a National Health Commission exchange programme planned to perform 300 free cataract operations and to demonstrate surgery for glaucoma and corneal disease. The report quotes the team’s deputy director of ophthalmology saying that more than 200 operations […]
-
AI-assisted summary
Beijing’s health commission reports on the 2026 services-trade health showcase
The Beijing Municipal Health Commission said a release event for the health-services section of the 2026 China International Fair for Trade in Services was held at Shougang Park on 10 September 2026. The commission’s account says the event published lists of advances in health service trade and in capital health research, promoted an AI-in-medicine project […]